Peer Review Congress Chicago – Day 3

Good morning from Chicago! We will start Day 3 (last day) of the 10th International Congress on Peer Review and Scientific Publication. @peerreviewcongress.bsky.social / peerreviewcongress.org/peer-review-… #PRC10 <— This hashtag will give you all the posts! You can also click on this feed, created by @retropz.bsky.social: bsky.app/profile/did:…

[Day 1] and [Day 2].

Continue reading “Peer Review Congress Chicago – Day 3”

Peer Review Congress Chicago – Day 2

[Day 1] [Day 3]

Good morning from Chicago, where we are getting ready for Day 2 of the 10th International Congress on Peer Review and Scientific Publication. peerreviewcongress.org / @peerreviewcongress.bsky.social / #PRC10

Continue reading “Peer Review Congress Chicago – Day 2”

Peer Review Congress Chicago – Day 1

It’s Peer Review Week! A perfect time to post my notes from the 10th International Congress on Peer Review and Scientific Publication, which was held at the Swissôtel in Chicago, two weeks ago, September 3-5, 2025.

This was my first time attending this congress. I tried to live-post all the talks on BlueSky [except for one session where I sneaked out].

You can find most posts about this conference under the hashtag #PRC10 on BlueSky or X. Andrew Porter @retropz.bsky.social, Research Integrity and Training Adviser at the Cancer Research UK Manchester Institute, created a BlueSky feed as well.

This post will contain (lightly edited) notes from Day 1. Click here to see the posts from [Day 2] and [Day 3].

Continue reading “Peer Review Congress Chicago – Day 1”

ScienceGuardians, where disgruntled authors complain about PubPeer

On Twitter/X, @SciGuardians, associated with the website ScienceGuardians.com, is promising to ‘uncover’ some big conspiracy of fraudulent @pubpeer.com users.

But in reality, the account appears to be run by one or more disgruntled scientists with dozens of problematic papers. And there is no big reveal.

Continue reading “ScienceGuardians, where disgruntled authors complain about PubPeer”

Science Integrity Digest, September 2024

An overview of general news and articles about science integrity and some cases that I have worked on.

Science sleuths

Neuroscientist and top NIH official under scrutiny

Q-Collar under scrutiny

Nobel prize winner under scrutiny

Paper Mills

New ORI regulations

The US Office of Research Integrity updated its regulations on handling research misconduct allegations. Key updates include clarifying the inquiry process and adjusting how institutions should handle the allegations and record the process.

1 in 7 scientific articles might be fake

James Heathers published a preprint arguing that the old, often-cited number that 2% of papers are fake is outdated and a vast underestimate. In a new preprint, he argues it might be 1 in 7 papers, based on 12 studies that together analyze 75,000 scientific articles.

Francesca Gino lawsuit

Around the world

New Publication and Editorials

Retraction Watch’s Weekend Reads:

Problems in Harvard Medical School studies include images taken from other researchers’ papers and vendor websites

Over the last week I’ve been analyzing a set of papers from a research group at Brigham and Women’s Hospital, which falls under the Harvard Medical School. The papers have the usual image problems we unfortunately encounter so often, such as duplicated photos of mice and overlapping Western blots.

But this set also includes a 2022 paper that appears to have copied/pasted several figure panels from other researchers and even from scientific vendors. Most of these problems were found with ImageTwin or reverse image searches.

Quick links [the spreadsheet and slide have been updated with an additional problem found on Feb 2, 2024]:

  • spreadsheet with the 28 29 papers found with PubPeer links [Excel file]
  • slide deck with the 58 59 image problems found in the 28 29 papers [PDF].
An image that appears to have been copied from a scientific seller’s website.
See: https://pubpeer.com/publications/FF5706E8826CB8D45481E942A679EE
Continue reading “Problems in Harvard Medical School studies include images taken from other researchers’ papers and vendor websites”

Problematic Papers from Zhejiang University

This post describes a set of over 20 papers with mostly image problems from the Department of Pharmacology at the School of Medicine of Zhejiang University in Hangzhou, China. All papers have Professor Ximei Wu as the common – and often corresponding – author. The Wu lab conducts research on stem cell and bone development, and their papers contain many images of Western blots and immunohistochemistry experiments.

Continue reading “Problematic Papers from Zhejiang University”

Cassava Sciences: Of Posters and Spaghetti Plots

In a previous blog post, I took a look at Western blots in papers from the lab of Dr. Hoau-Yan Wang at City University of New York (CUNY), mostly related to Cassava Sciences (Nasdaq: $SAVA), its predecessor Pain Therapeutics INC, and its flagship Alzheimer’s Disease drug candidate Simufilam.

While those papers were mainly about the preclinical Simufilam data, here I will review a conference poster reporting on Phase 2 data obtained by Cassava Sciences.

Continue reading “Cassava Sciences: Of Posters and Spaghetti Plots”

Worst paper of 2020? 5G and Coronavirus induction

This paper made my jaw drop:

5G Technology and induction of coronavirus in skin cells – M Fioranelli et al. – J Biol Regul Homeost Agents 2020 Jul 16;34(4). doi: 10.23812/20-269-E-4 [archivedPDF]

The paper suggests that 5G waves (the latest cell phone technology) can spontaneously generate Coronaviruses in skin cells. Yet, there is nothing in this article that proves this extraordinary claim. It is absolute nonsense.

Combining two hot topics into one title, this article is surely asking for some attention. Attention it will get. Because it is one of the worst scientific papers I have seen this year.

Continue reading “Worst paper of 2020? 5G and Coronavirus induction”

Post-publication reviews on COVID-19 papers

We are in the midst of a viral pandemic with huge effects on human health, social interactions, and the economy. Suddenly, lots of people have opinions or claim to have solutions to solve the COVID-19 situation. Not surprisingly, the Coronavirus epidemic has led to an enormous input of scientific papers, editorials, letters, reviews, trials, and what have you not. Most of these have been written hastily, without the rigor and thoughtfulness and editing that are normally essential to scientific publishing. Some of these papers are great, many of them not so much. Social media is exploding with all kinds of post-publication reviews of heavily discussed scientific papers. This post is an attempt to collect critical reviews of some of these COVID-19 related scientific papers.

Continue reading “Post-publication reviews on COVID-19 papers”